blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2199411

EP2199411 - Epigenetic markers for the identification of CD3 positive T-lymphocytes [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.03.2016
Database last updated on 26.06.2024
Most recent event   Tooltip06.10.2017Lapse of the patent in a contracting state
New state(s): CY, HU, MT
published on 08.11.2017  [2017/45]
Applicant(s)For all designated states
Epiontis GmbH
Rudower Chaussee 29
12489 Berlin / DE
[2010/25]
Inventor(s)01 / Olek, Sven
Boothstrasse 16
12207 Berlin / DE
02 / Türbachova, Ivana
Boothstrasse 16
12207 Berlin / DE
 [2010/25]
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[N/P]
Former [2015/19]Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Patentanwälte Rechtsanwälte
Pettenkoferstrasse 20-22
80336 München / DE
Former [2010/25]Krauss, Jan
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date08021838.116.12.2008
[2010/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2199411
Date:23.06.2010
Language:EN
[2010/25]
Type: B1 Patent specification 
No.:EP2199411
Date:06.05.2015
Language:EN
[2015/19]
Search report(s)(Supplementary) European search report - dispatched on:EP13.07.2009
ClassificationIPC:C12Q1/68
[2010/25]
CPC:
C12Q1/6881 (EP,US); C12Q2600/156 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/19]
Former [2010/25]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Epigenetische Marker zur Identifikation von CD3+ T-Lymphozyten[2010/25]
English:Epigenetic markers for the identification of CD3 positive T-lymphocytes[2010/25]
French:Marqueurs épigénétiques pour l'identification des lymphocytes T CD3+[2010/25]
Examination procedure25.11.2010Examination requested  [2011/01]
17.01.2011Despatch of a communication from the examining division (Time limit: M04)
26.05.2011Reply to a communication from the examining division
28.01.2013Despatch of a communication from the examining division (Time limit: M04)
29.05.2013Reply to a communication from the examining division
06.11.2014Cancellation of oral proceeding that was planned for 12.11.2014
12.11.2014Date of oral proceedings (cancelled)
04.12.2014Communication of intention to grant the patent
24.03.2015Fee for grant paid
24.03.2015Fee for publishing/printing paid
24.03.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.01.2011
Opposition(s)09.02.2016No opposition filed within time limit [2016/15]
Fees paidRenewal fee
15.12.2010Renewal fee patent year 03
12.12.2011Renewal fee patent year 04
11.12.2012Renewal fee patent year 05
12.12.2013Renewal fee patent year 06
11.12.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.12.2008
CY06.05.2015
EE06.05.2015
ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
MT06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
PT07.09.2015
[2017/40]
Former [2016/24]EE06.05.2015
ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
PT07.09.2015
Former [2016/10]EE06.05.2015
ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
PT07.09.2015
Former [2016/09]EE06.05.2015
ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
PT07.09.2015
Former [2015/50]ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
PT07.09.2015
Former [2015/49]ES06.05.2015
HR06.05.2015
LT06.05.2015
LV06.05.2015
GR07.08.2015
PT07.09.2015
Documents cited:Search[X]  - FLANAGAN B F ET AL, "DNASE HYPERSENSITIVITY AND METHYLATION OF THE HUMAN CD3G AND D GENES DURING T-CELL DEVELOPMENT", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, (19900101), vol. 31, no. 1, ISSN 0093-7711, pages 13 - 20, XP009113698 [X] 1-19 * the whole document *
 [X]  - CLEVERS H ET AL, "AN ENHANCER LOCATED IN A CPG-ISLAND 3' TO THE TCR-CD3-EPSILON GENE CONFERS T LYMPHOCYTE-SPECIFICITY TO ITS PROMOTER", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (1989), vol. 8, no. 9, ISSN 0261-4189, pages 2527 - 2536, XP002519563 [X] 1,13 * abstract * * page 2529, column 2, paragraph 3 - page 2531, column 2, paragraph 1 *
 [A]  - TUTT LANDOLFI M M ET AL, "Specific demethylation of the CD4 gene during CD4 T lymphocyte differentiation.", MOLECULAR IMMUNOLOGY JAN 1997, (199701), vol. 34, no. 1, ISSN 0161-5890, pages 53 - 61, XP002519564 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0161-5890(96)00104-6
 [A]  - LUSSO P ET AL, "Induction of CD4 and susceptibility to HIV-1 infection in human CD8<+> T lymphocytes by human herpesvirus 6", NATURE 1991 GB, (1991), vol. 349, no. 6309, ISSN 0028-0836, pages 533 - 535, XP002519565 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1038/349533a0
 [A]  - GEORGOPOULOS K ET AL, "A T cell-specific enhancer is located in a DNase I-hypersensitive area at the 3' end of the CD3-delta gene.", THE EMBO JOURNAL AUG 1988, (198808), vol. 7, no. 8, ISSN 0261-4189, pages 2401 - 2407, XP002519566 [A] 1-19 * the whole document *
by applicantEP1213360
 WO2004050706
 EP1826279
    - ANTEQUERA; BIRD, PROC NATL ACAD SCI USA, (1993), vol. 90, pages 11995 - 9
    - JONES; LAIRD, NATURE GENETICS, (1999), vol. 21, pages 163 - 167
    - ESTELLER, ONCOGENE, (2002), vol. 21, pages 5427 - 5440
    - LAIRD, NATURE, (2003), vol. 3, pages 253 - 266
    - LAIRD, NATURE REVIEWS/CANCER, (2003), vol. 3, pages 253 - 266
    - HAMERMAN JA; PAGE ST; PULLEN AM, "Distinct methylation states of the CD8 beta gene in peripheral T cells and intraepithelial lymphocytes", J IMMUNOL., (19970801), vol. 159, no. 3, pages 1240 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.